Carol J Levy1, Nicole C Foster2, Stephanie N DuBose2, Shivani Agarwal3, Sarah K Lyons4, Anne L Peters5, Gabriel I Uwaifo6, Linda A DiMeglio7, Jennifer L Sherr8, Sarit Polsky9. 1. Icahn School of Medicine at Mount Sinai, NY, USA. 2. Jaeb Center for Health Research, Tampa, FL, USA. 3. Fleischer Institute of Diabetes and Metabolism, Center for Diabetes Translational Research, Albert Einstein College of Medicine, Bronx, NY, USA. 4. Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA. 5. Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA. 6. Ochsner Medical Center, New Orleans, LA, USA. 7. Indiana University, School of Medicine, Indianapolis, IN, USA. 8. Yale School of Medicine, New Haven, CT, USA. 9. Barbara Davis Center for Diabetes, Aurora, CO, USA.
Abstract
OBJECTIVES: To examine changes in device use and glycemic outcomes for pregnant women from the T1D Exchange Clinic Registry between the years 2010-2013 and 2016-2018. METHODS: Participant-reported device use and glycemic outcomes were compared for women aged 16-40 years who were pregnant at the time of survey completion, comparing 2010-2013 (cohort 1) and 2016-2018 (cohort 2). Hemoglobin A1c results within 30 days prior to survey completion were obtained from medical records. RESULTS: There were 208 pregnant women out of 5,236 eligible participants completing the questionnaire in cohort 1 and 47 pregnant women out of 2,818 eligible participants completing the questionaire in cohort 2. Continuous glucose monitor (CGM) use while pregnant trended upward among cohort 2 (70% vs 37%, P = .02), while reported continuous subcutaneous insulin infusion (CSII) use while pregnant declined (76% vs 64%, P = .04). HbA1c levels trended downward (6.8% cohort 1 vs 6.5% cohort 2, P = .07). CONCLUSIONS: Self-reported CGM use while pregnant increased over the studied intervals whereas CSII use decreased. Additional evaluation of device use and the potential benefits for T1D pregnancies is needed.
OBJECTIVES: To examine changes in device use and glycemic outcomes for pregnant women from the T1D Exchange Clinic Registry between the years 2010-2013 and 2016-2018. METHODS: Participant-reported device use and glycemic outcomes were compared for women aged 16-40 years who were pregnant at the time of survey completion, comparing 2010-2013 (cohort 1) and 2016-2018 (cohort 2). Hemoglobin A1c results within 30 days prior to survey completion were obtained from medical records. RESULTS: There were 208 pregnant women out of 5,236 eligible participants completing the questionnaire in cohort 1 and 47 pregnant women out of 2,818 eligible participants completing the questionaire in cohort 2. Continuous glucose monitor (CGM) use while pregnant trended upward among cohort 2 (70% vs 37%, P = .02), while reported continuous subcutaneous insulin infusion (CSII) use while pregnant declined (76% vs 64%, P = .04). HbA1c levels trended downward (6.8% cohort 1 vs 6.5% cohort 2, P = .07). CONCLUSIONS: Self-reported CGM use while pregnant increased over the studied intervals whereas CSII use decreased. Additional evaluation of device use and the potential benefits for T1D pregnancies is needed.
Entities:
Keywords:
continuous glucose monitor; female; pregnancy; type 1 diabetes
Authors: Zoe A Stewart; Malgorzata E Wilinska; Sara Hartnell; Leanne K O'Neil; Gerry Rayman; Eleanor M Scott; Katharine Barnard; Conor Farrington; Roman Hovorka; Helen R Murphy Journal: Diabetes Care Date: 2018-03-13 Impact factor: 19.112
Authors: Nicole C Foster; Roy W Beck; Kellee M Miller; Mark A Clements; Michael R Rickels; Linda A DiMeglio; David M Maahs; William V Tamborlane; Richard Bergenstal; Elizabeth Smith; Beth A Olson; Satish K Garg Journal: Diabetes Technol Ther Date: 2019-01-18 Impact factor: 6.118
Authors: Melissa M Kallas-Koeman; Jason M Kong; Jennifer A Klinke; Sonia Butalia; Abhay K Lodha; Ken I Lim; Qiuli M Duan; Lois E Donovan Journal: Diabetologia Date: 2014-01-17 Impact factor: 10.122
Authors: Sarit Polsky; Mengdi Wu; Bruce W Bode; Stephanie N DuBose; Robin S Goland; David M Maahs; Nicole C Foster; Anne L Peters; Carol J Levy; Viral N Shah; Roy W Beck Journal: Diabetes Technol Ther Date: 2018-07-10 Impact factor: 6.118
Authors: Zoe A Stewart; Malgorzata E Wilinska; Sara Hartnell; Rosemary C Temple; Gerry Rayman; Katharine P Stanley; David Simmons; Graham R Law; Eleanor M Scott; Roman Hovorka; Helen R Murphy Journal: N Engl J Med Date: 2016-08-18 Impact factor: 91.245
Authors: Anna L Secher; Lene Ringholm; Henrik U Andersen; Peter Damm; Elisabeth R Mathiesen Journal: Diabetes Care Date: 2013-01-24 Impact factor: 19.112
Authors: Basak Ozaslan; Carol J Levy; Yogish C Kudva; Jordan E Pinsker; Grenye O'Malley; Ravinder Jeet Kaur; Kristin Castorino; Camilla Levister; Mari Charisse Trinidad; Donna Desjardins; Mei Mei Church; Mitchell Plesser; Shelly McCrady-Spitzer; Selassie Ogyaadu; Kristen Nelson; Corey Reid; Sunil Deshpande; Walter K Kremers; Francis J Doyle; Barak Rosenn; Eyal Dassau Journal: Diabetes Technol Ther Date: 2022-04-26 Impact factor: 7.337
Authors: Grenye O'Malley; Barak Rosenn; Emily V Nosova; Yogish C Kudva; Sophia Scarpelli Shchur; Camilla Levister; Ravinder Kaur; Jordan E Pinsker; Kristin Castorino; Mei Mei Church; Eyal Dassau; Carol J Levy Journal: J Diabetes Sci Technol Date: 2021-07-03